sleep apnoea
Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity
April 18, 2024Research and Development Ear Nose & throat, Eli Lilly, clinical trial, sleep apnoea, tirzepatide
Eli Lilly has announced positive topline results from its SURMOUNT-OSA phase 3 trials which demonstrated that tizepatide injection (10mg or …
ZOLL remedē System receives FDA approval for sleep apnoea treatment
May 25, 2023Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea
ZOLL Medical Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for its …
FDA authorises Jazz Pharma’s sleep disorder therapy Sunosi
March 22, 2019Medical Communications, Sales and Marketing FDA, jazz pharmaceuticals, pharma, sleep apnoea
Jazz Pharmaceuticals has announced that its dopamine and norepinephrine reuptake inhibitor (DNRI) Sunosi (solriamfetol) has been approved by the FDA …
Latest content
Five Facts about cardiovascular disease
August 9, 2026
